Parkwalk Knowledge Intensive EIS Fund V – Now Open

We are pleased to announce the launch of the Parkwalk Knowledge Intensive EIS Fund V (KI Fund V), an HMRC-approved EIS Fund. The fifth Knowledge Intensive Fund will back cutting-edge technology companies spun out of leading UK universities, mirroring the investment strategy of our Opportunities EIS Fund.

The KI Fund V can help investors reduce their income tax bills for 2024/25 and 2025/26, with only one EIS5 tax certificate. Find out more here.

London, UK, 08/12/2025 – Parkwalk Advisors, the UK’s most active investor in university spinouts (Beauhurst 2025), has launched its fifth Knowledge Intensive EIS Fund, which will invest in knowledge-intensive science and deep tech businesses from UK universities, whilst investors benefit from tax reliefs under the Enterprise Investment Scheme.

First launched in January 2021, Parkwalk’s Knowledge Intensive Funds have raised over £71 million to date. The fifth fund, which launches today, aims to raise a further £15 million for high-growth, knowledge intensive companies, whilst providing tax benefits to investors as a HMRC approved Enterprise Investment Scheme (EIS) fund. Knowledge Intensive EIS Funds have the advantage of providing investors with tax relief at a pre-determined date (linked to the Fund close date) and with only one tax certificate, they offer a reduced administrative burden.

The fund will target innovative deeptech and science companies spun out from some of the UK’s leading universities. Parkwalk’s previous funds have backed companies such as PhasecraftBrainomix and PervasID, as well as veterinary biopharmaceutical company PetMedix, which exited for a multiple return as one of the first successful exits for a Knowledge Intensive EIS Fund.

Moray Wright, chief executive at Parkwalk, said: “Parkwalk has led the way in deploying tax-efficient investment to nurture and grow cutting-edge UK companies. We’re incredibly proud to launch our latest Knowledge Intensive Fund, the fifth since 2021, as a continuation of our commitment to supporting our fast-growing science and deep tech sectors. The Fund will sit alongside our evergreen Parkwalk Opportunities EIS Fund and will give our investors a simpler way to invest in EIS and access to our deal flow network. Much like a VCT, the Knowledge Intensive EIS Fund provides only one tax certificate to investors.”

“Having raised the largest KI Fund last tax year we look forward to announcing further investments for KI Fund IV.  With plentiful deal flow and a seasoned investment team, our fifth KI Fund in the series is well positioned to invest in the groundbreaking deeptech businesses that are emerging from the UK’s world-leading universities.”

With £450 million of assets under management, Parkwalk has invested in over 180 companies across its Parkwalk Opportunities and Knowledge Intensive EIS Funds, as well as the award-winning enterprise and innovation earlier stage investment funds Parkwalk manages for the Universities of Cambridge, Oxford, Bristol and Imperial College. Parkwalk also launched its first ever Northern Universities Venture Fund earlier this year, in conjunction with Northern Gritstone, investing in companies spun out from the universities of Leeds, Liverpool, Manchester and Sheffield.

Parkwalk was the first major EIS fund manager to launch a Knowledge Intensive EIS Fund in 2021. The Enterprise Investment Scheme is a government backed scheme which has provided tax relief to investors in spinouts and start-ups for 30 years. Through this scheme, Parkwalk has invested in numerous companies which have together secured over £2.5 billion in investment and generated over 5,000 skilled jobs.

Find out more about the Parkwalk Knowledge Intensive EIS Fund V here. To request Fund documentation please email our team sales@parkwalkadvisors.com

Parkwalk Advisors Limited (Parkwalk) is authorised and regulated by the Financial Conduct Authority: FRN 502237. Investments referred to in this news article are not suitable for all investors. Capital is at risk and investors may not get back the full amount invested. Any investment in a Parkwalk product must only be made on the basis of the terms of the full Information Memorandum. Tax treatment depends on the individual circumstances of each investor. Parkwalk is not able to provide advice as to the suitability of investing in any product. Past performance is not a reliable indicator of future results. This financial promotion was approved in December 2025.

The products shown on this website will place your capital at risk and investors may not get back the full amount invested. Past performance may not be repeated and is not indicative of future results.

Parkwalk funds invest in smaller and unquoted companies which carry a higher risk than many other forms of investment. There is no guarantee that target returns will be achieved. There is no liquid market for shares in unquoted companies and there can be difficulties, in valuing and disposing of investments in such companies. Tax reliefs will depend on the investors’ individual circumstance and are subject to change.

Parkwalk does not provide investment or tax advice, and the information on this website should not be construed as such. Parkwalk recommends investors seek advice from a regulated financial adviser that specialises in EIS fund investments before making an investment decision. An investment into any of the funds managed by Parkwalk may only be made on the basis of the information set out in the Information Memorandum and Key Information Document.

The information on this website is directed at United Kingdom residents only. Please confirm you have read this warning and are happy to proceed.

Do not invest unless you are prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.